Shift workers are at increased risk of severe COVID-19 compared with day workers: Results from the international COVID sleep study (ICOSS) of 7141 workers.


Journal

Chronobiology international
ISSN: 1525-6073
Titre abrégé: Chronobiol Int
Pays: England
ID NLM: 8501362

Informations de publication

Date de publication:
02 2023
Historique:
medline: 3 5 2023
pubmed: 23 11 2022
entrez: 22 11 2022
Statut: ppublish

Résumé

The present study had two main aims. First, to investigate whether shift/night workers had a higher prevalence and severity of COVID-19 compared with day workers. Second, to investigate whether people regularly working in face-to-face settings during the pandemic exhibited a higher prevalence and severity of COVID-19 compared with those having no need to be in close contact with others at work. Data consisted of 7141 workers from 15 countries and four continents who participated in the International COVID Sleep Study-II (ICOSS-II) between May and December 2021. The associations between work status and a positive COVID-19 test and several indications of disease severity were tested with chi-square tests and logistic regressions adjusted for relevant confounders. In addition, statistical analyses were conducted for the associations between face-to-face work and COVID-19 status. Results showed that shift/night work was not associated with an increased risk of COVID-19 compared to day work. Still, shift/night workers reported higher odds for moderate to life-threatening COVID-19 (adjusted odds ratio (aOR) = 2.71, 95%-confidence interval = 1.23-5.95) and need for hospital care (aOR = 5.66, 1.89-16.95). Face-to-face work was associated with an increased risk of COVID-19 (aOR = 1.55, 1.12-2.14) but not with higher disease severity. In conclusion, shift/night work was not associated with an increased risk of COVID-19, but when infected, shift/night workers reported more severe disease. Impaired sleep and circadian disruption commonly seen among shift/night workers may be mediating factors. Working face-to-face increased the risk of COVID-19, likely due to increased exposure to the virus. However, face-to-face work was not associated with increased disease severity.

Identifiants

pubmed: 36412198
doi: 10.1080/07420528.2022.2148182
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-122

Auteurs

Bjørn Bjorvatn (B)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway and Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway.

Ilona Merikanto (I)

SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland and Orton Orthopaedics Hospital, Helsinki, Finland.

Catia Reis (C)

Universidade Católica Portuguesa, Católica Research Centre for Psychological, Family and Social Wellbeing, Lisbon, Portugal and Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina de Lisboa, Lisboa, Portugal.

Maria Korman (M)

Department of Occupational Therapy, Faculty of Health Sciences, Ariel University, Ariel, Israel.

Adrijana Koscec Bjelajac (AK)

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

Brigitte Holzinger (B)

Institute for Consciousness and Dream Research, Medical University of Vienna, Wien, Postgraduate, Sleep Coaching, Vienna, Austria.

Luigi De Gennaro (L)

Department of Psychology, Sapienza University of Rome, Roma, Lazio, Italy and IRCCS Fondazione Santa Lucia, Roma, Italy.

Yun Kwok Wing (YK)

Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Charles M Morin (CM)

Centre de recherche CERVO/Brain Research Center, École de psychologie, Université Laval, Quebec, Quebec, Canada.

Colin A Espie (CA)

Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Christian Benedict (C)

Department of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, Uppsala, Sweden.

Anne-Marie Landtblom (AM)

Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Kentaro Matsui (K)

Department of Clinical Laboratory, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Harald Hrubos-Strøm (H)

Department of Otorhinolaryngology, Akershus University Hospital, Lørenskog, Norway and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Sérgio Mota-Rolim (S)

Brain Institute, Physiology and Behavior Department and Onofre Lopes University Hospital, Federal University of Rio Grande do Norte, Natal, Brazil.

Michael R Nadorff (MR)

Department of Psychology, Mississippi State University, Mississippi, Mississippi, USA.

Giuseppe Plazzi (G)

IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy; and Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Rachel Ngan Yin Chan (RNY)

Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Markku Partinen (M)

Department of Clinical Neurosciences, University of Helsinki Clinicum Unit, Helsinki, Finland and Helsinki Sleep Clinic, Terveystalo Healthcare Services, Helsinki, Finland.

Yves Dauvilliers (Y)

Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Institute for Neurosciences of Montpellier INM, INSERM, University of Montpellier, Montpellier, France.

Frances Chung (F)

Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.

Ingeborg Forthun (I)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway and Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH